RND Pump-Mediated Efflux of Amotosalen, a Compound Used in Pathogen Inactivation Technology to Enhance Safety of Blood Transfusion Products, May Compromise Its Gram-Negative Anti-Bacterial Activity
mSphere · 2023
DOI: 10.1128/msphere.00673-22 ↗Kurz gefasst
Fachartikel in der Zeitschrift mSphere, 2023. Verfasst von Alex B Green und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Membrane Transport Proteins, Furocoumarins. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, HHS | NIH | National Institute of Allergy and Infectious Diseases, HHS | NIH | NIH Clinical Center.
Abstract (Originalsprache)
Pathogen inactivation is a strategy to enhance the safety of transfused blood products. We identify the compound, amotosalen, widely used for pathogen inactivation, as a bacterial multidrug efflux substrate.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
- Harvard Medical School, Boston, Massachusetts, USA.
- Department of Pharmaceutical Sciences, School of Pharmacy, Bouvé College of Health Sciences, Northeastern University, Boston, Massachusetts, USA.
- Department of Pharmacology, Case Western Reserve University Medical Center, Cleveland, Ohio, USA.
- Department of Transfusion Medicine, NIH Clinical Center, National Institutes of Health Bethesda, Maryland, USA.
ORCID-Profile: Willy A Flegel, James E Kirby
Förderung
- NIAID NIH HHS
- HHS | NIH | National Institute of Allergy and Infectious Diseases
- HHS | NIH | NIH Clinical Center
Zitieren
APA
Green, A. B., Chiaraviglio, L., Truelson, K. A., Zulauf, K. E., Cui, M., Zhang, Z., Ware, M. P., Flegel, W. A., Haspel, R. L., Yu, E. W., & Kirby, J. E. (2023). RND Pump-Mediated Efflux of Amotosalen, a Compound Used in Pathogen Inactivation Technology to Enhance Safety of Blood Transfusion Products, May Compromise Its Gram-Negative Anti-Bacterial Activity. mSphere. https://doi.org/10.1128/msphere.00673-22
Vancouver
Green AB, Chiaraviglio L, Truelson KA, Zulauf KE, Cui M, Zhang Z, et al. RND Pump-Mediated Efflux of Amotosalen, a Compound Used in Pathogen Inactivation Technology to Enhance Safety of Blood Transfusion Products, May Compromise Its Gram-Negative Anti-Bacterial Activity. mSphere. 2023. doi:10.1128/msphere.00673-22
BibTeX
@article{Green2023,
author = {Green, Alex B and Chiaraviglio, Lucius and Truelson, Katherine A and Zulauf, Katelyn E and Cui, Meng and Zhang, Zhemin and Ware, Matthew P and Flegel, Willy A and Haspel, Richard L and Yu, Edward W and Kirby, James E},
title = {RND Pump-Mediated Efflux of Amotosalen, a Compound Used in Pathogen Inactivation Technology to Enhance Safety of Blood Transfusion Products, May Compromise Its Gram-Negative Anti-Bacterial Activity},
journal = {mSphere},
year = {2023},
doi = {10.1128/msphere.00673-22}
}
EUVIMED